Concepedia

Publication | Open Access

The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19

DOIFull Paper Access

117

Citations

20

References

2020

Year

Gholamali Eslami, Sajedeh Mousaviasl, Esmat Radmanesh, Saeed Jelvay, Saeid Bitaraf, Bryony Simmons, Hannah Wentzel, Andrew Hill, Anahita Sadeghı, James A. Freeman,
Journal of Antimicrobial Chemotherapy

Abstract

Given these encouraging initial results, and the current lack of treatments proven to decrease mortality in COVID-19, further investigation in larger-scale trials seems warranted.

References

YearCitations

Page 1